| ||||
| ||||
Marty: My weekend was fine, thanks. Saw family and spent some time with good friends. Also spent some time on line reading MOL messages. Kathy in Boise P.S. It would be neat if everyone told where they're from, wouldn't it? I'm so curious about other places.
-----Original Message-----
From: Martin Auslander [SMTP:fitecancer@earthlink.net]
Sent: Sunday, October 25, 1998 9:36 PM
To: Medical On Line Forum
Subject: [MOL] For Kathy in Boise
DEar Kathy in Boise (that sounds so poetic), like sleepless in 'Seattle.
Well anyway, thanks for your message. HOpe your weekend was as special
as it has been with us. We view each day as a cancer free day and seek
it as the joys and blessings of life. Sometimes that happens and
sometimes that doesnt, but the planning is great and the rewards when
that does happen is even better. So hope your weekend was special.
God Bless
marty
jerry corrigan wrote:
>
> Good morning, Marty. So nice to hear from you on a lovely Saturday morning.
> Good morning everyone, come to think of it! I feel good today, Norman is
> fine (sleeping at my feet) and Jerry (spousal unit) is fixing breakfast.
> We're going shopping later and then meeting my daughter and her fiance' for
> dinner. Should be a nice day. Love you all -- Kathy in Boise
> -----Original Message-----
> From: Martin Auslander <fitecancer@earthlink.net>
> To: Medical On Line Forum <mol-cancer@lists.meds.com>
> Date: Saturday, October 24, 1998 6:27 AM
> Subject: [MOL] New technique may save leukemia patients
>
> >Another Message for you this beautiful Sat morning. Have a great day and
> >hope the following information is very positive to you and those that
> >are seeking ways and means to overcome this disease.
> >
> >God Bless
> >marty auslander
> >
> >
> >BOSTON (UPI) - A groundbreaking new technique will help save
> >people dying of leukemia who cannot find an ideal donor for a
> >bone marrow transplant, say researchers.
> >
> >http://www.intelihealth.com/enews?199920
> >_
> >
> >Cord blood transplants have 50% success rate
> >
> >NEW YORK (Reuters) -- In about 50% of cases, umbilical cord blood
> >transplants have restored immunity in children who had hereditary
> >bone marrow abnormalities that impaired their immunity or whose
> >bone marrow was destroyed by cancer treatment, according to Dr.
> >Joanne Kurtzberg, a pioneer in the recently developed procedure.
> >
> >http://www.intelihealth.com/enews?199875
> >_
> >
> >FDA expands prescribed aspirin uses
> >
> >NEW YORK (Reuters) -- The US Food and Drug Administration (FDA)
> >announced substantial expansions to the recommended prescribed
> >uses of aspirin on Wednesday.
> >
> >http://www.intelihealth.com/enews?199876
> >
> >------------------------------
> >
> >Date: Fri, 23 Oct 1998 17:18:51 -0400
> >From: Robert Tollen <mensabrain@IBM.NET>
> >Subject: Class I HLA matching,
> > myeloablation enhance stem cell transplant success
> >
> >Class I HLA matching, myeloablation enhance stem cell transplant
> >success
> >
> >WESTPORT Oct 22 (Reuters) - Even if bone marrow donors are
> >matched to recipients for HLA-A, B and DR antigens, genomic
> >typing of class I HLA alleles can substantially increase
> >transplantation success, according to a report in the October
> >22nd issue of The New England Journal of Medicine. In a second
> >paper in the journal, Israeli and Italian researchers report
> >successful transplantation using T-cell depleted hematopoietic
> >stem cells matched for only one haplotype by prior conditioning
> >of.
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
|
